Your browser doesn't support javascript.
loading
Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma.
Liang, Zhiyu; Li, Ping; Kang, Liqing; Zhou, Lili; Xu, Yang; Ye, Shiguang; Du, Juan; Li, Bing; Wang, Yiwen; Yu, Lei; Qian, Wenbin; Liang, Aibin.
Afiliação
  • Liang Z; Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China.
  • Li P; Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China.
  • Kang L; Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Zhou L; Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China.
  • Xu Y; Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China.
  • Ye S; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Du J; Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China.
  • Li B; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai, China; and.
  • Wang Y; Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China.
  • Yu L; Shanghai World Foreign Language Academy, Shanghai, China.
  • Qian W; Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Liang A; Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China.
Blood Adv ; 6(1): 293-296, 2022 01 11.
Article em En | MEDLINE | ID: mdl-34758063
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Plasmócitos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Plasmócitos / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article